| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2689323 | Clinical Nutrition | 2015 | 6 Pages |
Abstract
The evidence from available RCTs does not indicate that PGX intake causes reductions in body weight. PGX may cause reductions in total and LDL cholesterol. Few trials examining the effects of PGX have been conducted; they are characterized by small sample sizes, deficiencies in reporting quality, and are funded by a single manufacturer. Future clinical trials evaluating its effect should be adequately powered and better reported.
Related Topics
Health Sciences
Medicine and Dentistry
Critical Care and Intensive Care Medicine
Authors
Igho J. Onakpoya, Carl J. Heneghan,